Retatrutide is quickly becoming one of the most talked-about compounds in the peptide and weight loss community. As a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, early research shows it may outperform both semaglutide and tirzepatide for weight reduction.
What Is Retatrutide?
Retatrutide (LY3437943) is an investigational compound originally developed by Eli Lilly. Phase 2 trials showed average weight loss exceeding 24% of body weight at 48 weeks — numbers that have generated enormous interest in the peptide research community. While not yet FDA-approved, compounded retatrutide is being used by many researchers and self-experimenters.
Retatrutide Vial Sizes and Handling
Compounded retatrutide typically comes in 3mL or 5mL lyophilized vials that require reconstitution with bacteriostatic water before use. The reconstituted solution should be refrigerated at 2-8°C and used within 28-30 days. Protect from light and avoid freezing.
Why Vial Storage Matters Even More for Retatrutide
Because retatrutide is expensive and not yet widely available, protecting each vial is critical. VialLock's hard-shell 3D printed cases are purpose-built to prevent breakage — snug-fit grid slots hold each vial securely with no rattling, no contact between vials, and no risk of breakage from bag drops or compression.
Which VialLock Case for Retatrutide?
- 2-Vial Essential — minimalist, pocket-sized for single-vial protocols
- 4-Vial Essential — ideal for users stacking retatrutide with BPC-157 or other peptides
- 8-Vial Pro — for serious researchers managing multiple compounds and doses
All VialLock cases use snug-fit 3mL slots compatible with standard compounded retatrutide vials. Shop VialLock cases and protect your retatrutide investment.